Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) is down considerably this morning after noting a ‘going concern’ note just yesterday.  Shares are down over 17% at $1.38 on the day.

Eli Lilly & Co. (NYSE: ELY) is large enough that this might be nothing more than a PR blunder.  Still, thieves stole as much as $75 million worth of the company’s drugs from a Connecticut warehouse over the weekend.  D
uring or after the weekend storms in the Northeast, thieves disabled a burglar alarm in the building and left with dozens of pallets loaded with the antidepressants Prozac and Cymbalta, as well as the anti-psychotic Zyprexa and other prescriptions.  They must be happy thieves, or at least no longer care.  With a $40 billion market cap and with Thomson Reuters having 2010 sales estimates of almost $23.3 billion, shares are basically flat at $36.20.

And there are a couple of analyst calls impacting shares as well.  GTX Inc. (NASDAQ: GTXI) is down 2.6% at $3.34 this morning. Rodman & Renshaw decided today was a good day to downgrade the stock to “Underperform” from Market Perform.”  Shire plc (NASDAQ: SHPGY) is down 1.75% at $66.13 on more than a whole day’s volume after Citigroup cut the company to a “Sell” rating down from a “Buy” rating it previously had.

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) is up strong on two issues. TheStreet.com via Real Money ‘bought shares’ and the company is presenting data at an upcoming Barclays conference.

JON C. OGG